The target price lets investors set an expected value for an asset, helping define buy or sell points.
Choose whether you would like to receive an alert for your Target Price.
The target price lets investors set an expected value for an asset, helping define buy or sell points.
This asset and the price you set will be removed from your target price list and this cannot be undone.
Congratulations! Your Target Price strategy has reached 5 alerts. Now take the next step: upgrade and unlock unlimited alerts to capture every market opportunity.
Unlock unlimited alerts
type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/30/2025 | 01/08/2026 | 0.14300000 |
| Dividends | 12/31/2021 | 01/07/2022 | 0.003940 |
| Dividends | 12/14/2021 | 12/21/2021 | 0.11415000 |
| Dividends | 12/15/2020 | 12/23/2020 | 0.05178000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| NTRA | Stock | Healthcare | US$ 56.02 B | 9,89% | |
| GH | Stock | Healthcare | US$ 22.62 B | 9,66% | |
| KRYS | Stock | Healthcare | US$ 9.04 B | 4,86% | |
| LGND | Stock | Healthcare | US$ 6.27 B | 4,62% | |
| ADPT | Stock | Healthcare | US$ 4.12 B | 4,18% | |
| TWST | Stock | Healthcare | US$ 9.45 B | 3,94% | |
| BBIO | Stock | Healthcare | US$ 14.42 B | 3,16% | |
| UTHR | Stock | Healthcare | US$ 26.10 B | 2,88% | |
| MEDP | Stock | Healthcare | US$ 18.56 B | 2,85% | |
| VRTX | Stock | Healthcare | US$ 134.44 B | 2,70% | |
| LLY | Stock | Healthcare | US$ 1.26 T | 2,69% | |
| REGN | Stock | Healthcare | US$ 100.69 B | 2,48% | |
| CDNA | Stock | Healthcare | US$ 4.65 B | 2,38% | |
| TVTX | Stock | Healthcare | US$ 4.66 B | 2,25% | |
| GRAL | Stock | Healthcare | US$ 6.42 B | 2,08% | |
| VYLR | Stock | Financial | US$ 48.01 B | 2,03% | |
| TEM | Stock | Healthcare | US$ 14.19 B | 2,00% | |
| RGEN | Stock | Healthcare | US$ 11.40 B | 1,93% | |
Charles River Laboratories
|
CRL | Stock | Healthcare | US$ 16.80 B | 1,80% |
| NBIX | Stock | Healthcare | US$ 16.81 B | 1,55% | |
| ARGX | Stock | Healthcare | US$ 56.67 B | 1,35% | |
| JAZZ | Stock | Healthcare | US$ 14.91 B | 1,33% | |
| KNSA | Stock | Healthcare | US$ 7.55 B | 1,13% | |
| VCYT | Stock | Healthcare | US$ 4.22 B | 1,13% | |
| PTCT | Stock | Healthcare | US$ 5.76 B | 1,10% | |
| RPRX | Stock | Healthcare | US$ 38.37 B | 1,07% | |
| BNTX | Stock | Healthcare | US$ 22.49 B | 1,03% | |
| HNGE | Stock | Healthcare | US$ 9.43 B | 1,02% | |
| IQV | Stock | Healthcare | US$ 43.27 B | 1,02% | |
| TXG | Stock | Healthcare | US$ 8.51 B | 0,98% | |
| TMO | Stock | Healthcare | US$ 258.75 B | 0,97% | |
| STOK | Stock | Healthcare | US$ 1.78 B | 0,95% | |
Sartorius Aktiengesellschaft
|
SRT3 | Stock | Healthcare | US$ 20.36 B | 0,95% |
| RVMD | Stock | Healthcare | US$ 42.80 B | 0,94% | |
| PRAX | Stock | Healthcare | US$ 7.83 B | 0,92% | |
Samsung Biologics Co Ltd
|
207940 | Stock | Healthcare | US$ 69.60 T | 0,92% |
| GMAB | Stock | Healthcare | US$ 34.14 B | 0,86% | |
| INSM | Stock | Healthcare | US$ 24.13 B | 0,82% | |
| CRSP | Stock | Healthcare | US$ 4.83 B | 0,79% | |
| MRNA | Stock | Healthcare | US$ 91.20 B | 0,70% | |
| A | Stock | Healthcare | US$ 49.95 B | 0,69% | |
| CDNS | Stock | Technology | US$ 90.41 B | 0,68% | |
|
First Tracks Biotherapeutics
|
TRAX | Stock | Healthcare | US$ 1.95 B | 0,68% |
| BEAM | Stock | Healthcare | US$ 2.73 B | 0,66% | |
| ANAB | Stock | Healthcare | US$ 1.43 B | 0,63% | |
| ETON | Stock | Healthcare | US$ 1.45 B | 0,63% | |
Glaukos Corp
|
GKOS | Stock | Healthcare | US$ 13.80 B | 0,61% |
| DHR | Stock | Healthcare | US$ 153.85 B | 0,61% | |
| QGEN | Stock | Healthcare | US$ 10.40 B | 0,56% | |
| AZN | Stock | Healthcare | US$ 285.18 B | 0,55% | |
| TGTX | Stock | Healthcare | US$ 9.30 B | 0,52% | |
| ARQT | Stock | Healthcare | US$ 4.02 B | 0,47% | |
Roivant Sciences Ltd
|
ROIV | Stock | Healthcare | US$ 26.03 B | 0,45% |
| AXSM | Stock | Healthcare | US$ 7.34 B | 0,40% | |
| CTVA | Stock | Basic Materials | US$ 58.62 B | 0,36% | |
Cogent Biosciences Inc
|
UMRX | Stock | Healthcare | US$ 73.23 M | 0,33% |
| CELC | Stock | Healthcare | US$ 3.41 B | 0,33% | |
| BIO | Stock | Healthcare | US$ 10.17 B | 0,29% | |
| RYTM | Stock | Healthcare | US$ 5.99 B | 0,28% | |
| BGNE | Stock | Healthcare | US$ 20.21 B | 0,27% | |
| TARS | Stock | Healthcare | US$ 3.40 B | 0,27% | |
Mineralys Therapeutics, Inc. Common Stock
|
MLYS | Stock | Healthcare | US$ 1.50 B | 0,25% |
|
Neurogene Inc
|
NGNE | Stock | Healthcare | US$ 533.70 M | 0,17% |
| WGS | Stock | Healthcare | US$ 2.07 B | 0,12% | |
| LQDA | Stock | Healthcare | US$ 4.24 B | 0,12% |
Average Investor10 user rating
4.0
(0 people)
Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $33.65 million.
Over the past 12 months, Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF recorded a return of 21.85%, with its price trading between $31.61 and $45.86 during the same period.
The ETF is traded under the ticker HELX.
The current price of HELX is $42.19. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
HELX is currently trading at $42.19, with a market capitalization of approximately $33.652.567,00. Over the past year, the ETF has delivered a 21.85% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in HELX through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol HELX, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, HELX has returned -1.54%, and 21.85% over the past year.
If you were to purchase 100 shares of HELX at the current price of $42.19, your total investment would be $4,219.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
